Keqiang Ye Selected Research

Infections

1/2018	Inhibition of IP6K1 suppresses neutrophil-mediated pulmonary damage in bacterial pneumonia.
5/2009	Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keqiang Ye Research Topics

Disease

45	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2014
36	Neoplasms (Cancer) 01/2021 - 10/2002
24	Cognitive Dysfunction 04/2024 - 01/2016
20	Parkinson Disease (Parkinson's Disease) 12/2023 - 02/2010
9	Amyloid Plaque 10/2023 - 01/2018
9	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 01/2005
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 10/2007
8	Inflammation (Inflammations) 01/2023 - 05/2009
7	Insulin Resistance 01/2022 - 04/2010
6	Memory Disorders (Memory Loss) 02/2024 - 02/2014
5	Obesity 01/2022 - 04/2010
5	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2005
4	Synucleinopathies 12/2023 - 01/2017
4	Motor Disorders 01/2022 - 11/2019
4	Ischemia 01/2018 - 03/2008
4	Stroke (Strokes) 10/2016 - 10/2007
3	Dementia (Dementias) 08/2023 - 05/2019
3	Peripheral Nerve Injuries 01/2023 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
3	Constipation 12/2021 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2011
3	Infarction (Infarctions) 01/2015 - 10/2007
2	Parkinsonian Disorders (Parkinsonism) 11/2023 - 01/2016
2	Brain Diseases (Brain Disorder) 10/2023 - 01/2019
2	Body Weight (Weight, Body) 01/2022 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 08/2012
2	Hyperlipidemias (Hyperlipidemia) 10/2018 - 01/2017
2	Infections 01/2018 - 05/2009
2	Carcinogenesis 11/2015 - 08/2013
2	Leukemia 08/2014 - 06/2008
2	Ganglion Cysts (Ganglion) 01/2014 - 07/2010

Drug/Important Bio-Agent (IBA)

35	asparaginylendopeptidase (legumain)IBA 11/2023 - 01/2009
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2005
20	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 07/2010
19	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2023 - 01/2017
14	SynucleinsIBA 01/2023 - 01/2017
12	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2015
10	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 01/2007
10	Phosphotransferases (Kinase)IBA 01/2022 - 10/2002
7	6,7-dihydroxyflavoneIBA 01/2021 - 02/2010
6	Apolipoprotein E4IBA 04/2024 - 01/2021
6	Netrin-1IBA 01/2022 - 01/2015
6	trkB ReceptorIBA 01/2022 - 03/2012
6	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 03/2009
5	LigandsIBA 10/2023 - 06/2011
5	LipidsIBA 01/2022 - 05/2009
5	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2018
5	Neurofibromin 2 (Merlin)IBA 11/2011 - 11/2004
4	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2024 - 01/2022
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
4	EnzymesIBA 11/2022 - 11/2012
4	AMP-Activated Protein KinasesIBA 01/2022 - 04/2010
4	CytokinesIBA 01/2021 - 01/2017
4	Dopamine (Intropin)FDA LinkGeneric 11/2019 - 12/2015
4	Protein Isoforms (Isoforms)IBA 12/2018 - 01/2005
4	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 03/2010 - 12/2004
3	Noscapine (Narcotine)IBA 04/2022 - 10/2002
3	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2013
3	ProdrugsIBA 01/2022 - 10/2016
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 07/2006
3	Insulin (Novolin)FDA Link 01/2022 - 04/2014
3	Small Interfering RNA (siRNA)IBA 10/2020 - 11/2012
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 02/2012
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2019 - 12/2015
3	Neuroprotective AgentsIBA 01/2018 - 12/2015
2	PresenilinsIBA 04/2024 - 01/2022
2	GonadotropinsIBA 02/2024 - 10/2023
2	tau Proteins (tau Protein)IBA 10/2023 - 04/2016
2	CCAAT-Enhancer-Binding ProteinsIBA 07/2023 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2023
2	CholesterolIBA 01/2022 - 01/2021
2	NetrinsIBA 01/2022 - 06/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2017
2	ElementsIBA 01/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	Apolipoproteins E (ApoE)IBA 10/2021 - 01/2018
2	ApolipoproteinsIBA 10/2021 - 01/2021
2	Netrin ReceptorsIBA 01/2021 - 01/2020
2	TropomyosinIBA 01/2021 - 05/2016
2	RotenoneIBA 01/2021 - 01/2020
2	NeurotoxinsIBA 01/2020 - 11/2019
2	Amyloid beta-PeptidesIBA 12/2018 - 10/2018
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 04/2010
2	alpha-Linolenic Acid (Linolenic Acid)IBA 10/2016 - 01/2016
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2016 - 12/2015
2	Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA 11/2015 - 08/2014
2	epidermal growth factor receptor VIIIIBA 07/2013 - 02/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013 - 01/2007
2	Serine (L-Serine)FDA Link 01/2013 - 06/2008
2	Arginine (L-Arginine)FDA Link 01/2013 - 06/2008
2	Nuclear Proteins (Protein, Nuclear)IBA 08/2012 - 09/2005
2	TOR Serine-Threonine KinasesIBA 02/2012 - 11/2007

Therapy/Procedure

7	Oral Administration 11/2023 - 02/2012
6	Therapeutics 01/2022 - 11/2007
2	Ovariectomy (Oophorectomy) 02/2024 - 01/2021
2	Radiotherapy 05/2016 - 05/2009